Skip Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

9 June 2020

Treatment of Dysphagia in Parkinson’s Disease: A Systematic Review

,
,
,
,
,
and
1
Health Research Centre, Department of Nursing, Physiotherapy and Medicine, University of Almería, Carretera del Sacramento s/n, La Cañada de San Urbano, 04120 Almería, Spain
2
Poniente Hospital, Ctra. de Almerimar, s/n, El Ejido, 04700 Almería, Spain
3
Distrito Sanitario Poniente, Jesús de Perceval, 22. El Ejido, 04700 Almería, Spain
4
Department of Psychology, University of Almería, Carretera del Sacramento s/n, La Cañada de San Urbano, 04120 Almería, Spain
This article belongs to the Special Issue Holistic Approaches to Understanding and Caring for Vulnerable Populations

Abstract

The incidence of oropharyngeal dysphagia in Parkinson’s disease (PD) is very high. It is necessary to search for effective therapies that could prevent pneumonia. Previous results should be interpreted cautiously as there is a lack of evidence to support the use of compensatory or rehabilitative approaches to dysphagia. We reviewed the scientific literature to describe the treatments of dysphagia in PD. A systematic review was performed in PubMed, Scopus, Elsevier, and Medline according to PRISMA standards in 2018. The articles that did not mention dysphagia secondary to PD or used surgical treatment were excluded. Eleven articles met the criteria with information from 402 patients. The review relates to different protocols, such as training in expiratory muscle strength, postural techniques, oral motor exercises, video-assisted swallowing therapy, surface electrical stimulation, thermal stimulation, touch, compensatory interventions, training regime for swallowing, neuromuscular electrical stimulation, Lee Silverman voice treatment, swallow maneuver, airway protection, and postural compensation maneuvers. This review identifies the rationing interventions in each trial, if they are efficient and equitable. Several rehabilitative therapies have been successful. An improvement was seen in the degenerative function (coordination, speed, and volume), quality of life, and social relationships of people with PD. Further investigations concerning the clinical applicability of these therapies based on well-designed randomized controlled studies are needed. Larger patient populations need to be recruited to evaluate the effectiveness, long-term effects, and new treatment techniques.

1. Introductions

Parkinson’s disease (PD) is a progressive and chronic neurodegenerative disorder, characterized by a deep and selective loss of dopaminergic neurons, with clinical manifestations including motor and nonmotor abnormalities [1,2]. PD is the second most common neurodegenerative disorder [3,4], and the average incidence rate estimated in developed countries is 14 cases per 100,000 people per year. If only subjects with 65 years or more age are considered, this rate increases to 160 cases per 100,000 persons per year. Mortality studies have shown the doubling of mortality rate in patients with PD compared with the general population. Given these epidemiological data, we can consider PD as a pathological disease with an enormous impact, which is expected to increase in the coming years, making it necessary to search for new therapies for PD [4]. In terms of prevalence, by taking into account all types of studies, in industrialized countries, the prevalence ranges from 0.3% to 1% in subjects with more than 60 years of age and reaches 3% in patients over 80 years of age. The number of studies on the prevalence, incidence, and mortality of PD has increased in recent years. Overall, prevalence and incidence vary widely across the world. The prevalence is higher in Europe and the United States than in other countries and distributed relatively evenly with a minimal range. In addition, PD increases mortality [5].
Among the leading causes of death in PD is pneumonia [6,7,8]. Langmore et al. [8] found that dysphagia is an important risk factor for the development of aspiration pneumonia when combined with other factors (such as feeding, functional, medical, or dental status; gastroesophageal reflux; colonization of the oropharynx with bacterial pathogens). Many of these are applicable to patients with PD. In addition, up to 80% of all patients will suffer from oropharyngeal dysphagia during the early stages of the disease. In the advanced stages of PD, the incidence of dysphagia may increase by up to 95% [9,10]. Treatment of dysphagia could, therefore, be one of the cornerstones for preventing pneumonia in PD patients [11,12].
Sensorimotor deficits affecting voice and swallowing ability can have a devastating impact on the quality of life of PD patients [13]. Former studies on the effects of speech and swallowing therapy in PD and physical and occupational therapy have demonstrated little or uncertain effects [12]. Nagaya et al. [10] evaluated the effect of swallowing training on dysphagia in PD without a control group and without an adequate baseline; therefore, its results should be interpreted cautiously. Sharkawi et al. [14] evaluated the effects of the Lee Silverman voice treatment (LVST) and found a 51% reduction in general swallowing disorders. A systematic review in 2010 revealed 19 publications that included targeted training for voice, and only one publication included targeted training for swallowing [13]. It is necessary to search for effective therapies that are useful in preventing pneumonia. The earlier results are not adequate for proper interpretation due to the lack of evidence to support the use of either compensatory or rehabilitative approaches in dysphagia. Our purpose was to organize and describe the benefits of different therapies in dysphagia associated with Parkinson’s disease in the last 10 years. Further research should be based on randomized controlled trials to determine the effectiveness and the clinical applicability of different therapies for dysphagia [11].
Dysphagia is a routine problem faced by health workers and family members. Dietary change and the use of thickeners are usual treatments, but they are also considerably expensive [15,16]. This study is justified because it is necessary to deepen research to identify the rationing instruments, which, if efficient and equitable, offer greater possibilities to improve health interventions in a population affected by neurological diseases that demand care processes and procedures that contribute to the quality of life [17,18]. In PD, ever more patients are dying from aspiration pneumonia [8]. Moreover, the quality of life is often diminished because PD does not allow patients to lead an active social life.
This study reviewed the scientific literature regarding the different techniques used to manage dysphagia in patients with PD.
The next section presents detailed information on the method employed in this review, which was based on the PRISMA guidelines [19]. All types of interventions and outcomes mentioned in the studies were included. This paper has intended to provide an overview of what is known about the treatments for dysphagia in PD, describing concise and precise updates on the progress made so far.

2. Methods

We performed a systematic review by following the PRISMA guidelines [19]. The articles were selected from the databases PubMed, Medline, Elsevier, and Scopus in 2018 by using the following descriptors in English: “Parkinson disease,” “disease of Parkinson,” “Parkinson disorders,” “deglutition disorders,” “dysphagia,” “oral care,” “mouth rehabilitation,” “rehabilitation,” “physical therapy specialty,” “physiotherapy,” “physiotherapy modalities,” and “physiotherapy treatment,”. In Spanish: “Parkinson,” “disfagia,” and “fisioterapia.”
The inclusion criteria were articles (clinical trials, pilot studies, and descriptive studies) that included a rehabilitation treatment or physiotherapy technique for patients with PD with dysphagia and should be published in the last ten years (from 2008 inclusive). Meta-analysis, systematic reviews, all articles that did not mention dysphagia secondary to PD or those that mentioned the application of surgical treatment were excluded.
Risk of bias assessment: the clinical trials were evaluated using the Jadad scale [20], a questionnaire that offers a score of 0 to 5, where the higher the score is, the better the methodological quality of the article. This scale includes five questions regarding randomization and the sequence; masking (as double-blind) and the method; and description of losses and exclusions (follow-up), with the answers ‘Yes’ (1 point) and ‘No’ (0 point). A clinical trial having a score of 5 is considered rigorous; a clinical trial having a score equal to or below 2 points is considered low-quality.

3. Results

The search strategy used to identify appropriate literature for this review within the databases is shown in Table 1. Figure 1 shows how articles were selected according to the study’s objective and the inclusion/exclusion criteria.
Table 1. Systematic syntax in the databases.
Figure 1. The selected articles from the databases.
With this search strategy, 233 studies were found and reviewed according to the title and abstract by two independent evaluators (JPE and RLL) using the Rayyan QCRI program (https://rayyan.qcri.org), to include only those that met the eligibility criteria of the study. We removed 13 duplicate studies and excluded 181 by title and content of the abstract. Disagreements were settled by consensus and, if needed, by a third reviewer. After an initial screening of the studies that were considered potentially relevant (39 articles), a full-text reading was carried out, paying special attention to the study design, the intervention (population, treatment type, number of sessions and duration), and other factors. Five full-text articles were excluded as they did not mention dysphagia secondary to PD; 14 articles did not include rehabilitative treatment, while nine were systematic reviews. Finally, eleven articles met this study’s objective and inclusion criteria.
The selected articles included information from 402 patients, where the information on the type of study, intervention, or technique performed, and the results obtained was found (Table 2).
Table 2. Study characteristics and main results.
An analysis of the content of studies included in this review, according to the variables included, is presented below.

3.1. Type of Study

Overall, five randomized controlled trials (9,21–24), two pilot studies (21,27) and four descriptive studies [25,28,29,30] were included.

3.2. Application of the Jadad Scale

Table 3 analyzes the methodological quality of the clinical trials included in this review. Most articles did not indicate the method used to generate the sequence of randomization, whether adequate blinding was performed, or the description of losses, abandonments, and patient follow-up.
Table 3. Risk of bias. Application of the Jadad scale to the clinical trials of this review.
Only one trial was of low quality according to the JADAD scale [20] (Table 3). All the studies asserted that they used a randomization method. Three studies got less score due to the lack of information on report losses and exclusions [22,23] or if the blinding of the evaluator and the participants was carried out according to the allocated group [9,22].
According to the results of the different studies, it is possible to state the reliability of the different methods of intervention assessed. Among those with better evidence, EMST may be a restorative and reliable treatment for dysphagia in those with PD [21,22,29]. In this same category would fall the video-assisted swallowing therapy (VAST), which proved reliable for patients with Parkinson’s disease [23]. On the other hand, the effects of neuromuscular electrical stimulation (NMES) as adjunct to therapy on the quality of life in patients with Parkinson’s disease and oropharyngeal dysphagia are found inconclusive [9,24,27]. This would also be the case for the effortful swallow maneuver reinforced by using biofeedback, the effects of bolus consistency, TTS, or motor swallowing exercises, as they all appear to be inconclusive therapeutic resources that need further evaluation [25,26,28,30].

3.3. Treatment/Intervention or Rehabilitation Techniques

Felix et al. [26] proposed the implementation of the swallow maneuver with effort (with biofeedback), a rehabilitation program that included eight maneuvers to facilitate swallowing. Swallowing with the exercise maneuver consisted of asking the patient “to swallow by contracting the muscles of the mouth and throat with the greatest possible force.”
Byeon [22] proposed a simultaneous treatment of postural techniques and expiratory muscular strength training in the improvement of swallowing function in patients with PD, since according to the author, improvements were observed when both techniques were applied at the same time (vitalization of the suprahyoid muscle, reduction of aspiration and opening of the upper esophageal sphincter). Regan et al. [30] demonstrated that tactile thermal stimulation (TTS) accelerates involuntary pharyngeal swallow.
Authors such as Troche, Byeon or Pitts et al. [21,22,29] proposed an EMST device to improve voluntary coughing, increasing the acceleration of cough volume. Troche et al. [21] promoted a restorative treatment (EMST) for dysphagia in PD in which the experimental group improved hyolaryngeal function and swallow safety compared to the sham group, with Class I evidence. Previously, Troche et al. (2008) suggested that thicker consistencies should yield a safer swallow in those with PD [28].
Argolo et al. [25] established oral motor exercises (10 repetitions of sustained vowel phonation of /a/, pushing of plosive phonemes in a forceful manner; sucking of wet gauze; tongue-hold swallowing; modified supraglottic maneuver (emission of /a/ vowel in a forceful manner) before breathing again. And five repetitions of ascending and descending gliding phonations of the vowels /a/ and /u/; and three series of five repetitions of tongue rotation, each side, in the oral vestibule. It positively impacted the quality of life and swallowing complaints.
Manor et al. [23] used video-assisted swallowing therapy (swallowing exercises and compensatory therapy technique carried out with different consistencies of food and liquid), which significantly decreased the presence of residues in the pharynx, and therefore improved swallowing. Speech therapy for dysphagia, in Baijens’s study, included rehabilitation techniques to improve or restore the swallowing physiology and to facilitate oral dietary intake, such as exercises to improve sensorimotor integration and muscle strength, as well as (postural) maneuvers [24].
Heijnen [9] made a comparative study of neuromuscular electrical stimulation at sensor or motor level and traditional therapy regarding the effect on the quality of life, but the differences between the groups were nonsignificant. Baijens et al. [27] attempted to demonstrate the effect of a surface electrical stimulation (SES) session using different electrode positions on PD patients with dysphagia, but the results were the same for both healthy control subjects and PD patients. The results could be attributed to the placebo effect in control subjects. These three studies [9,24,27] explored the effects of SES of the neck in patients with PD. The studies evaluated the traditional treatment of physiotherapy that consisted of maneuvers for the respiratory tract, postural compensation, modification of the bolus, and motor exercises together with SES. The results were not significant for SES but were significant when traditional physiotherapy techniques were applied [24].
Regarding the evaluation of dysphagia, different scales and measures were used in the articles: O’Neil Dysphagia Outcome and Severity Scale (DOSS) [26,30], a visual analogue scale, the Dysphagia Severity Scale (DSS) [9], and the Functional Dysphagia Scale, based on videofluoroscopic studies (VFS) [24].
Many studies used a Standardized Videofluoroscopic Swallowing (VFS) protocol [9,21,22,23,24,25,26,27,28,29,30], or fiber-optic endoscopic evaluation of swallowing (FEES) [9,23,24].
Swallow timing was assessed using a Digital Swallowing Workstation [28] or the oral and pharyngeal transit times were measured in milliseconds with the Avidemux software [25]. The questionnaire on swallowing disturbances evaluated the presence of swallowing problems [23].
The Penetration/Aspiration scale (P/A scale) was used to indicate the safest swallow [21,27,28,29]. Expiratory Muscle Strength Training (EMST) [25,29] was employed to measure the parameters of voluntary coughing.
The level of disability was measured through the Hoehn and Yahr scale in all studies [9,21,22,23,24,25,26,27,28,29,30]. Motor function or severity was assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS) [21]. The patient’s degree of enjoyment from food was assessed with the pleasure of eating scale [23]. Functional Oral Intake Scale (FOIS) [9] was used to evaluate the diet.
The quality of life was measured using the following scales: the Swallowing Quality of Life Questionnaire (SWAL-QOL) [9,21,23,25], MD Anderson Dysphagia Inventory [MDADI] [9] and the Swallowing Quality of Care (SWA-CARE) [23]. Cognition was evaluated using the Mini Mental State Examination (MMSE) [9,21,22,23,24,25,28].

4. Discussion

PD is becoming more frequent as the global human population is aging [3,4,26]. In PD, dysphagia is very common with serious and negative consequences for physical health and quality of life [31,32,33]. Despite this, there is not enough evidence to determine the quality of interventions being performed to treat dysphagia during PD [9,23,25,31]. Today, the most common treatment focuses on changing the texture of the diet, although there are other techniques aimed at improving the quality of life of the patients suffering from dysphagia [21,28]. Different techniques have been proposed by nurses, speech therapists, physiotherapists, occupational therapists, and doctors [9,21,22,23,24,25,26,27,28,29,30].
This systematic review identifies the rationing instruments and interventions in each trial. Several rehabilitative therapies as EMST or NMES have been successful in swallowing and reducing the risk of choking, aspiration or improving oropharyngeal function [9,21,22,29]. An improvement was seen in the degenerative function (coordination, speed, and volume), quality of life, and social relationships of people with PD [23,25]. However, some experimental intervention studies included a small or very small number of patients. Only 4 of 11 studies included more than 40 participants; therefore, the extent of results is also limited [9,21,23,24].
Most of the articles showed an improvement in the degenerative function after applying the described techniques and, thus, the improvement in the quality of life and relationship of these patients with the environment was notable [21,22,23,25,26]. However, SES did not show any positive influence in traditional speech therapy [24]. The frequency and duration need further investigation to construct a clinical decision-making model for the treatment options in this patient population.
Previously, another systematic review [34], based on the literature and experience of its research team, established a therapeutic strategy to improve PD symptoms such as dysphagia, posture, step, bradykinesia, depression, tremor, and loss of strength. Van Hooren, Baijens, Voskuilen et al. [11], in a systematic review where 12 articles were used, described different techniques as oral motor exercises, EMST, video-assisted swallowing therapy, surface electrical stimulation, thermal stimulation, touch, chewing gum effect. Another study [31] reviewed the literature on compensatory and rehabilitation interventions for dysphagia in PD and argued that rehabilitation methods could possibly have a greater potential to increase the safety of swallowing and, thus, to improve the quality of life. However, compensatory methods for the treatment of dysphagia have received more attention than rehabilitation methods, and yet, none of these have a strong evidence base.
Another article [35] showed that in the first three months after deep brain stimulation of the subthalamic nucleus, rehabilitation was required in a small proportion of patients with PD. This study supported the idea that a fast-track rehabilitation program, similar to that of Jiang et al. [36], may be useful but yet it would not be necessary for the entire surgical patient population. However, Gadenz’s systematic review described the benefits of the repetitive transcranial magnetic stimulation (noninvasive transcortical stimulation) and its applicability in these neurogenic disorders related to communication and deglutition, particularly from the studies on stroke patients, but this finding is still uncertain [37]. He described that some studies explored the stimulation of the dorsolateral prefrontal cortex because it could improve clinical symptoms, including speech-language impairment in PD [37,38].
This review has evaluated 11 studies that assessed the effects of different therapies for swallowing disorders due to PD, and all of them used a standardized videofluoroscopic swallowing protocol for an objective evaluation [9,21,22,23,24,25,26,27,28,29,30].
The data collected in the anamnesis, clinical, and instrumental evaluation of PD patients should be detailed to provide an understanding of the disorder and its diagnosis and promote treatment planning and treatment evolution [9,11,21,22,23,24,25,26,27,28,29,30]. Some of the scales and measures that had been used to evaluate these patients with dysphagia were the Dysphagia severity scale, the oral and pharyngeal transit time, the swallowing disturbances questionnaire, the penetration/aspiration scale, expiratory muscle strength, the unified Parkinson’s disease rating scale, the pleasure of eating scale, the functional oral intake scale, the swallowing quality of life questionnaire, the MD Anderson Dysphagia Inventory, and the Swallowing quality of care questionnaire [9,21,22,23,24,25,26,27,28,29,30].
The risk of bias, as evaluated by the JADAD scale [20] in the clinical trials, indicated that most studies had good methodological quality, although some of them did not report the blinding method or describe losses and exclusions. Further research is needed to expand the knowledge about new treatments and techniques in PD.

Limitations and Future Perspectives

The limitations of this review article are directly related to the limitations of the selected articles. Most articles used a small sample, so the results are not sufficiently reliable, and thus the authors propose that larger samples should be recruited for future studies [22,25,26,27,28,30]. Another limitation is the patients’ knowledge of the applied therapy, so in many cases, the effect could have been due to the placebo effect and not to the technique itself.
In order to mitigate some of the effects or limitations of this review, we employed comprehensive search strategies to avoid biases in the information gathering process, making a critical assessment and synthesis of the studies. In addition, the data obtained were extremely heterogeneous because of the differences between the designs and therapies or rehabilitation interventions applied in the reviewed studies.
As research on this topic becomes more rigorous, further revisions will be required on interventions that have changed or improved over time. As dysphagia rehabilitation is a central aspect of the working of a speech-language therapist in many countries, this term “speech-language therapy” could be considered in future reviews and more articles can be retrieved in the search.
There is insufficient scientific evidence to compare the effectiveness of the various techniques described, and well-designed studies are needed to determine the value of the exercises used in the various fields of application, with appropriate follow-up. Most of the studies that we reviewed state that physiotherapeutic treatment for dysphagia in PD accelerates swallowing improvements.
We would like to highlight the importance of well-designed experimental research that overcomes the limitations observed and obtains more reliable results on the treatment of dysphagia, as dysphagia is a serious and vital sequela of PD. A multidisciplinary team should be informed and prepared to offer a correct intervention in PD. Once the investigations are more rigorous on the subject, further revisions will be required.
More work needs to be done to establish or define what type of therapies, rehabilitation techniques, exercises, or maneuvers are the most effective in dysphagia and to develop agreed protocols. These interventions need to be evaluated with regard to intensity, frequency, duration, consistency, side effects, institution versus home based, individualized versus standardized training, practicability in real life, and quality standards [12]. It is essential to optimize the quality of PD care and minimize its cost, in order to make it efficient and equitable where it is provided [18].

5. Conclusions

This review compiled several techniques and treatments used for swallowing problems in PD patients, such as compensation strategies, swallow maneuvering, expiratory muscle strength training, together with postural treatment, traditional physiotherapy techniques, muscular training of the tongue, pharynx, larynx, and respiratory apparatus, and surface and neuromuscular electrical stimulation. Most of the results obtained with the application of these techniques described in the selected articles support an improvement in the degenerative function, even though these results are not of high quality in most of the studies. Further investigations concerning the clinical applicability of these therapies based on well-designed randomized controlled trials are needed with larger patient populations. This will give a correct estimate of the effectiveness, long-term effects, and the possibility of new techniques.

Author Contributions

Conceptualization, R.L.-L. and J.P.-E.; methodology, J.M.A.-P., R.T.-R., M.J.M.-G., and F.A.V.-R.; software, J.M.A.-P., R.T.-R., M.J.M.-G., and F.A.V.-R.; validation, R.L.-L., J.P.-E., P.R.-P., and F.A.V.-R.; formal analysis, J.M.A.-P., and R.T.-R.; investigation, all authors; data curation, all authors; writing—original draft preparation, R.L.-L., J.P.-E., and P.R.-P.; writing—review and editing, R.L.-L., J.P.-E., P.R.-P., J.M.A.-P., R.T.-R., M.J.M.-G., and F.A.V.-R; visualization, R.L.-L., J.P.-E., P.R.-P., J.M.A.-P., R.T.-R., M.J.M.-G., and F.A.V.-R; supervision, R.L.-L., and P.R.-P. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gómez-Regueira, N.; Escobar-Velando, G. Tratamiento fisioterapéutico de las alteraciones posturales en la enfermedad de Parkinson. Revisión sistemática. Fisioterapia 2017, 39, 33–43. [Google Scholar] [CrossRef]
  2. Ba, X.-H. Therapeutic effects of GM1 on Parkinson’s disease in rats and its mechanism. Int. J. Neurosci. 2015, 126, 163–167. [Google Scholar] [CrossRef] [PubMed]
  3. Tysnes, O.-B.; Storstein, A. Epidemiology of Parkinson’s disease. J. Neural Transm. 2017, 124, 901–905. [Google Scholar] [CrossRef] [PubMed]
  4. Wirdefeldt, K.; Adami, H.-O.; Cole, P.; Trichopoulos, D.; Mandel, J.S. Epidemiology and etiology of Parkinson’s disease: A review of the evidence. Eur. J. Epidemiol. 2011, 26, 1–58. [Google Scholar] [CrossRef] [PubMed]
  5. León, J.B. Epidemiología de la enfermedad de Parkinson en España y su contextualización mundial. Revista de Neurología 2018, 66, 125. [Google Scholar] [CrossRef]
  6. Yoritaka, A.; Shimo, Y.; Takanashi, M.; Fukae, J.; Hatano, T.; Nakahara, T.; Miyamato, N.; Urabe, T.; Mori, H.; Hattori, N. Motor and non-motor symptoms of 1453 patients with Parkinson’s disease: Prevalence and risks. Park. Relat. Disord. 2013, 19, 725–731. [Google Scholar] [CrossRef]
  7. Sato, K.; Hatano, T.; Yamashiro, K.; Kagohashi, M.; Nishioka, K.; Izawa, N.; Mochizuki, H.; Hattori, N.; Mori, H.; Mizuno, Y.; et al. Prognosis of Parkinson’s disease: Time to stage III, IV, V, and to motor fluctuations. Mov. Disord. 2006, 21, 1384–1395. [Google Scholar] [CrossRef] [PubMed]
  8. Langmore, S.; Terpenning, M.S.; Schork, A.; Chen, Y.; Murray, J.T.; Lopatin, D.; Loesche, W.J. Predictors of aspiration pneumonia: How important is dysphagia? Dysphagia 1998, 13, 69–81. [Google Scholar] [CrossRef]
  9. Heijnen, B.J.; Speyer, R.; Baijens, L.W.J.; Bogaardt, H. Neuromuscular electrical stimulation versus traditional therapy in patients with parkinson’s disease and oropharyngeal dysphagia: Effects on quality of life. Dysphagia 2011, 27, 336–345. [Google Scholar] [CrossRef]
  10. Nagaya, M.; Kachi, T.; Yamada, T.; Igata, A. videofluorographic study of swallowing in parkinson’s disease. Dysphagia 1998, 13, 95–100. [Google Scholar] [CrossRef]
  11. Van Hooren, M.R.A.; Baijens, L.; Voskuilen, S.; Oosterloo, M.; Kremer, B. Treatment effects for dysphagia in Parkinson’s disease: A systematic review. Park. Relat. Disord. 2014, 20, 800–807. [Google Scholar] [CrossRef]
  12. Ransmayr, G. Physical, occupational, speech and swallowing therapies and physical exercise in Parkinson’s disease. J. Neural Transm. 2011, 118, 773–781. [Google Scholar] [CrossRef] [PubMed]
  13. Russell, J.A.; Ciucci, M.R.; Connor, N.P.; Schallert, T. Targeted exercise therapy for voice and swallow in persons with Parkinson’s disease. Brain Res. 2010, 1341, 3–11. [Google Scholar] [CrossRef]
  14. Sharkawi, A.E.; Ramig, L.; Logemann, J.A.; Pauloski, B.R.; Rademaker, A.W.; Smith, C.H.; Pawlas, A.; Baum, S.; Werner, C. Swallowing and voice effects of Lee Silverman Voice. J. Neurol. Neurosurg. Psychiatry 2002, 72, 31–37. [Google Scholar] [CrossRef] [PubMed]
  15. Evatt, M.L. Nutritional therapies in Parkinson’s disease. Curr. Treat. Options Neurol. 2007, 9, 198–204. [Google Scholar] [CrossRef] [PubMed]
  16. Crary, M.A.; Sura, L.; Madhavan, A.; Carnaby-Mann, G. Dysphagia in the elderly: Management and nutritional considerations. Clin. Interv. Aging 2012, 7, 287–298. [Google Scholar] [CrossRef] [PubMed]
  17. Rizek, P.; Kumar, N.; Jog, M. An update on the diagnosis and treatment of Parkinson disease. Can. Med. Assoc. J. 2016, 188, 1157–1165. [Google Scholar] [CrossRef] [PubMed]
  18. De Roos, P.; Bloem, B.R.; Kelley, T.A.; Antonini, A.; Dodel, R.; Hagell, P.; Marras, C.; Martinez-Martin, P.; Mehta, S.H.; Odin, P.; et al. A Consensus set of outcomes for Parkinson’s disease from the international consortium for health outcomes measurement. J. Park. Dis. 2017, 7, 533–543. [Google Scholar] [CrossRef]
  19. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, U.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef]
  20. Clark, H.D.; Wells, G.A.; Huët, C.; McAlister, F.A.; Salmi, L.R.; Fergusson, D.; Laupacis, A. Assessing the quality of randomized trials: Reliability of the Jadad scale. Control. Clin. Trials 1999, 20, 448–452. [Google Scholar] [CrossRef]
  21. Troche, M.S.; Sapienza, C.M.; Rosenbek, J.C. Effects of bolus consistency on timing and safety of swallow in patients with Parkinson’s disease. Dysphagia 2007, 23, 26–32. [Google Scholar] [CrossRef] [PubMed]
  22. Byeon, H. Effect of simultaneous application of postural techniques and expiratory muscle strength training on the enhancement of the swallowing function of patients with dysphagia caused by Parkinson’s disease. J. Phys. Ther. Sci. 2016, 28, 1840–1843. [Google Scholar] [CrossRef] [PubMed]
  23. Manor, Y.; Mootanah, R.; Freud, D.; Giladi, N.; Cohen, J.T. Video-assisted swallowing therapy for patients with Parkinson’s disease. Park. Relat. Disord. 2013, 19, 207–211. [Google Scholar] [CrossRef] [PubMed]
  24. Baijens, L.; Speyer, R.; Passos, V.L.; Pilz, W.; Van Der Kruis, J.; Haarmans, S.; Desjardins-Rombouts, C. Surface electrical stimulation in dysphagic parkinson patients: A randomized clinical trial. Laryngoscope 2013, 123, 38–44. [Google Scholar] [CrossRef] [PubMed]
  25. Argolo, N.; Sampaio, M.; Pinho, P.; Melo, A.; Nóbrega, A.C. Do swallowing exercises improve swallowing dynamic and quality of life in Parkinson’s disease? Neurorehabilitation 2013, 32, 949–955. [Google Scholar] [CrossRef]
  26. Felix, V.N.; Corrêa, S.M.A.; Soares, R.J. A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson’s disease. Clinics 2008, 63, 661–666. [Google Scholar] [CrossRef][Green Version]
  27. Baijens, L.; Speyer, R.; Passos, V.L.; Pilz, W.; Roodenburg, N.; Clavé, P. The effect of surface electrical stimulation on swallowing in dysphagic Parkinson patients. Dysphagia 2012, 27, 528–537. [Google Scholar] [CrossRef] [PubMed]
  28. Troche, M.S.; Okun, M.S.; Rosenbek, J.C.; Musson, N.; Fernandez, H.H.; Rodriguez, R.; Romrell, J.; Pitts, T.; Hegland, K.W.; Sapienza, C.M. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: A randomized trial. Neurology 2010, 75, 1912–1919. [Google Scholar] [CrossRef]
  29. Pitts, T.; Bolser, D.; Rosenbek, J.; Troche, M.; Okun, M.S.; Sapienza, C. Impact of Expiratory Muscle Strength Training on Voluntary Cough and Swallow Function in Parkinson Disease. Chest 2009, 135, 1301–1308. [Google Scholar] [CrossRef]
  30. Regan, J.; Walshe, M.; Tobin, W.O. Immediate effects of thermal–tactile stimulation on timing of swallow in idiopathic Parkinson’s disease. Dysphagia 2009, 25, 207–215. [Google Scholar] [CrossRef]
  31. Smith, S.K.; Roddam, H.; Sheldrick, H. Rehabilitation or compensation: Time for a fresh perspective on speech and language therapy for dysphagia and Parkinson’s disease? Int. J. Lang. Commun. Disord. 2012, 47, 351–364. [Google Scholar] [CrossRef] [PubMed]
  32. Borrione, P.; Tranchita, E.; Sansone, P.; Parisi, A. Effects of physical activity in Parkinson’s disease: A new tool for rehabilitation. World J. Methodol. 2014, 4, 133–143. [Google Scholar] [CrossRef] [PubMed]
  33. Fox, C.; Ebersbach, G.; Ramig, L.; Sapir, S. LSVT LOUD and LSVT BIG: Behavioral treatment programs for speech and body movement in Parkinson disease. Park. Dis. 2012, 2012, 1–12. [Google Scholar] [CrossRef] [PubMed]
  34. Jöbges, E.M.; Spittler-Schneiders, H.; Renner, C.; Hummelsheim, H. Clinical relevance of rehabilitation programs for patients with idiopathic Parkinson syndrome. II: Symptom-specific therapeutic approaches. Park. Relat. Disord. 2007, 13, 203–213. [Google Scholar] [CrossRef]
  35. Tassorelli, C.; Buscone, S.; Sandrini, G.; Pacchetti, C.; Furnari, A.; Zangaglia, R.; Bartolo, M.; Nappi, G.; Martignoni, E. The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: A pilot study. Park. Relat. Disord. 2009, 15, 675–681. [Google Scholar] [CrossRef]
  36. Jiang, Y.; Norman, K.E. Effects of visual and auditory cues on gait initiation in people with Parkinson’s disease. Clin. Rehabil. 2006, 20, 36–45. [Google Scholar] [CrossRef]
  37. Gadenz, C.D.; Capobianco, D.M.; Cassol, M.; Moreira, T.D.C. Effects of repetitive transcranial magnetic stimulation in the rehabilitation of communication and deglutition disorders: Systematic review of randomized controlled trials. Folia Phoniatr. Logop. 2015, 67, 97–105. [Google Scholar] [CrossRef]
  38. Dias, A.E.; Barbosa, E.R.; Coracini, K.; Maia, F.; Marcolin, M.A.; Fregni, F. Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson’s disease. Acta Neurol. Scand. 2006, 113, 92–99. [Google Scholar] [CrossRef]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.